Lipocine Ownership | Who Owns Lipocine?


OverviewForecastRevenueFinancialsChart

Lipocine Ownership Summary


Lipocine is owned by 9.89% institutional investors, 2.84% insiders, and 87.27% retail investors. Vanguard group is the largest institutional shareholder, holding 4.15% of LPCN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.66% of its assets in Lipocine shares.

LPCN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLipocine9.89%2.84%87.27%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group221.87K4.15%$634.54K
Blackrock funding, inc. /de89.27K1.67%$254.43K
Geode capital management61.08K1.14%$174.70K
Renaissance36.10K0.67%$102.88K
State street18.63K0.35%$53.27K
Northern trust13.16K0.25%$37.51K
Dimensional fund advisors lp12.14K0.23%$34.72K
Barclays9.41K0.18%$26.82K
Advisor group2.27K0.04%$6.46K
Ubs group1.77K0.03%$5.03K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caldwell sutter capital471.000.00%$1.34K
Tower research capital llc (trc)1.17K0.00%$3.33K
Renaissance36.10K0.00%$102.88K
Tidemark59.00-$168.00
Northern trust13.16K-$37.51K
Dimensional fund advisors lp12.14K-$34.72K
State street18.63K-$53.27K
Jpmorgan chase---
Group one trading162.00-$463.00K
Ubs group1.77K-$5.03K

Top Buyers

HolderShares% AssetsChange
Renaissance36.10K0.00%1.30K
Ubs group1.77K-1.29K
Tower research capital llc (trc)1.17K0.00%497.00
Fmr59.00-59.00
Citigroup3.00-3.00

Top Sellers

HolderShares% AssetsChange
Dimensional fund advisors lp12.14K--11.72K
Vanguard group221.87K--3.01K
Advisor group2.27K--19.00
Jpmorgan chase---11.00
Tidemark59.00--

New Positions

HolderShares% AssetsChangeValue
Citigroup3.00-3.00$9.00

Sold Out

HolderChange
Jpmorgan chase-11.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252116.67%529,3070.16%910.14%716.67%4-33.33%
Jun 30, 202518-5.26%528,3562.10%910.55%5-54.55%7133.33%
Mar 31, 20251911.76%517,4736.33%911.64%11120.00%3-25.00%
Dec 31, 202417-5.56%486,671-10.62%98.79%5-50.00%4-
Sep 30, 202418-544,5242.43%1010.29%10---100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv142.77K2.66%-3.12K
Vanguard US Total Market Shares ETF141.08K2.64%-
Vanguard Institutional Extnd Mkt Idx Tr51.03K0.95%-23.25K
Fidelity Extended Market Index29.34K0.54%-242.00
Vifag 2002 SICAV17.77K0.33%-
BlackRock Extended Equity Market K12.86K0.24%-5.00
Extended Equity Market Fund K12.47K0.23%-249.00
Fidelity Total Market Index8.74K0.16%-
Dimensional US Targeted Value ETF8.13K0.15%-
Spartan Extended Market Index Pool F8.00K0.15%242.00

Recent Insider Transactions


DateNameRoleActivityValue
May 25, 2023Patel Mahesh V. CEO and PresidentBuy$43.79K
Mar 24, 2023Patel Mahesh V. CEO and PresidentBuy$48.00K
Mar 20, 2023Ono Richard Dana-Buy$1.36K
Mar 17, 2023Patel Mahesh V. CEO and PresidentBuy$16.50K
Nov 22, 2022Papapetropoulos Spyros-Buy$10.22K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

LPCN Ownership FAQ


Who Owns Lipocine?

Lipocine shareholders are primarily institutional investors at 9.89%, followed by 2.84% insiders and 87.27% retail investors. The average institutional ownership in Lipocine's industry, Biotech Stocks , is 45.22%, which Lipocine falls below.

Who owns the most shares of Lipocine?

Lipocine’s largest shareholders are Vanguard group (221.87K shares, 4.15%), Blackrock funding, inc. /de (89.27K shares, 1.67%), and Geode capital management (61.08K shares, 1.14%). Together, they hold 6.95% of Lipocine’s total shares outstanding.

Does Blackrock own Lipocine?

BlackRock is not among the top 10 institutional shareholders of Lipocine.

Who is Lipocine’s biggest shareholder by percentage of total assets invested?

Caldwell sutter capital is Lipocine’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 471 Lipocine shares, valued at 1.34K$.

Who is the top mutual fund holder of Lipocine shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lipocine shares, with 2.66% of its total shares outstanding invested in 142.77K Lipocine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools